Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer

This study has been completed.

Study NCT00072319 Information provided by National Cancer Institute (NCI)

First Received: November 4, 2003 Last Updated: December 13, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	November 2006 (Final data collection date for primary outcome measure)